Publication | Open Access

ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with Type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension

Metabolic SyndromeHypertensionHepatologyMedicineLiver PhysiologyPhysiologyDiabetesType 2Ace-inhibition IncreasesInsulin ManagementArterial HypertensionDiabetes MellitusPharmacologyInsulin SignalingHealth Sciences